Cargando…
Association of anxiety, depression and resilience with overall health and functioning in axial spondyloarthritis (axSpA): a cross-sectional study
OBJECTIVES: To evaluate the association between anxiety, depression and resilience with overall health and functioning in axial spondyloarthritis (axSpA). DESIGN: Cross-sectional evaluation of baseline data from a prospective cohort study, with recruitment from January 2018 to March 2021. SETTING: O...
Autores principales: | Chung, Deborah Xin Yi, Loo, Ying Ern, Kwan, Yu Heng, Phang, Jie Kie, Woon, Ting Hui, Goh, Wei Rui, Angkodjojo, Stanley, Fong, Warren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174021/ https://www.ncbi.nlm.nih.gov/pubmed/37156581 http://dx.doi.org/10.1136/bmjopen-2023-071944 |
Ejemplares similares
-
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
por: Robinson, Philip C., et al.
Publicado: (2019) -
Sera of patients with axial spondyloarthritis (axSpA) enhance osteoclastogenic potential of monocytes isolated from healthy individuals
por: Korkosz, Mariusz, et al.
Publicado: (2018) -
Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?
por: Maksymowych, Walter P., et al.
Publicado: (2023) -
Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS
por: Macfarlane, Gary J, et al.
Publicado: (2020) -
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA
por: van der Heijde, Désirée, et al.
Publicado: (2017)